[HTML][HTML] How to use biomarkers of infection or sepsis at the bedside: guide to clinicians

P Póvoa, L Coelho, F Dal-Pizzol, R Ferrer… - Intensive care …, 2023 - Springer
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host
response to infection. In this context, biomarkers could be considered as indicators of either …

[HTML][HTML] Update advances on C-reactive protein in COVID-19 and other viral infections

Y Luan, C Yin, Y Yao - Frontiers in immunology, 2021 - frontiersin.org
Severe coronavirus disease 2019 (COVID-19) can manifest as a viral-induced
hyperinflammation with multiorgan dysfunction. It has been documented that severe COVID …

Guidelines for the management of adult lower respiratory tract infections‐Full version

M Woodhead, F Blasi, S Ewig, J Garau… - Clinical microbiology …, 2011 - Wiley Online Library
Clin Microbiol Infect 2011; 17 (Suppl. 6): E1–E59 Abstract This document is an update of
Guidelines published in 2005 and now includes scientific publications through to May 2010 …

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

WS Lim, SV Baudouin, RC George, AT Hill… - Thorax, 2009 - thorax.bmj.com
SYNOPSIS OF RECOMMENDATIONS A summary of the initial management of patients
admitted to hospital with suspected community acquired pneumonia (CAP) is presented in …

[HTML][HTML] Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD

M Bafadhel, TW Clark, C Reid, M Medina, S Batham… - Chest, 2011 - Elsevier
Background Antibiotic overuse in respiratory illness is common and is associated with drug
resistance and hospital-acquired infection. Biomarkers that can identify bacterial infections …

[HTML][HTML] Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention–Update 2016

S Ewig, G Höffken, WV Kern, G Rohde, H Flick… - …, 2016 - thieme-connect.com
Die vorliegende Leitlinie umfasst ein neues und aktualisiertes Konzept der Behandlung und
Prävention von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die …

Interpretation of C‐reactive protein concentrations in critically ill patients

C Lelubre, S Anselin… - BioMed research …, 2013 - Wiley Online Library
Infection is often difficult to recognize in critically ill patients because of the marked
coexisting inflammatory process. Lack of early recognition prevents timely resuscitation and …

[HTML][HTML] Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study

M Lampart, N Zellweger, S Bassetti, S Tschudin-Sutter… - PloS one, 2022 - journals.plos.org
Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

[PDF][PDF] Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch …

WJ Wiersinga, MJ Bonten, WG Boersma, RE Jonkers… - Neth J …, 2018 - researchgate.net
Community-acquired pneumonia (CAP) is defined as an acute symptomatic infection of the
lower respiratory tract which in general develops outside of a hospital or nursing home …

[HTML][HTML] C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study

P Póvoa, AM Teixeira-Pinto, AH Carneiro… - Critical care, 2011 - Springer
Introduction C-reactive protein (CRP) has been shown to be a valuable marker in the
diagnosis of infection and in monitoring its response to antibiotics. Our objective was to …